United Therapeutics Corporation beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $6.83 | — | — | Miss |
| Q12026 FY2026 | $6.73 | $5.82 | -13.5% | Miss |
| Q42025 FY2025 | $6.78 | $7.70 | +13.6% | Beat |
Back to UTHR overview · UTHR holders · UTHR KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.